Horrell Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Horrell Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,048	Closed	-$6K	–	189
2016 Q2	$6K	Hold	1,048	–	–	﹤0.01%	160
2016 Q1	$5K	Hold	1,048	–	–	﹤0.01%	159
2015 Q4	$5K	Hold	1,048	–	–	﹤0.01%	155
2015 Q3	$3K	Hold	1,048	–	–	﹤0.01%	186
2015 Q2	$3K	Hold	1,048	–	–	﹤0.01%	196
2015 Q1	$3K	Hold	1,048	–	–	﹤0.01%	302
2014 Q4	$5K	Hold	1,048	–	–	﹤0.01%	278
2014 Q3	$5K	Hold	1,048	–	–	﹤0.01%	279
2014 Q2	$6K	Hold	1,048	–	–	﹤0.01%	273
2014 Q1	$4K	Hold	1,048	–	–	﹤0.01%	266
2013 Q4	$3K	Hold	1,048	–	–	﹤0.01%	277
2013 Q3	$3K	Hold	1,048	–	–	﹤0.01%	270
2013 Q2	$2K	Buy	+1,048	New	+$2.31K	﹤0.01%	290

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Horrell Capital Management's ENZ Position: Q3 2016 in Review

Horrell Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2016, closing a stake of 1,048 shares — an estimated $6K sold.

Horrell Capital Management first reported a position in ENZ in Q2 2013 and held it in 13 quarters. The position peaked at $6K in Q2 2016. 111 funds tracked by Wall St. Rank hold ENZ as of Q3 2016.

Horrell Capital Management reported no remaining Enzo Biochem, Inc. position as of Q3 2016 after selling out during the quarter.
Horrell Capital Management sold 1,048 Enzo Biochem, Inc. shares in Q3 2016, an estimated $6K.
Horrell Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 13 quarters.
Horrell Capital Management's Enzo Biochem, Inc. position peaked at $6K in Q2 2016.
111 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2016.

Based on Horrell Capital Management's 13F filing for Q3 2016, filed 20 Oct 2016.